What are the Beers Criteria?

The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults are guidelines that list medications generally considered unsafe or ineffective in older adults, or those where safer alternatives exist, for specific conditions or situations.

Who developed and maintains the Beers Criteria?

Originally developed by Dr. Mark Beers in the early 1990s, the criteria are now regularly updated and maintained by the American Geriatrics Society (AGS), with the latest update published in 2023.

Why are the Beers Criteria important in geriatric pharmacy?

They serve as a vital tool for healthcare professionals, especially pharmacists, to identify and reduce the risk of adverse drug events (ADEs), improve medication safety, and optimize drug therapy for older adults, who are more susceptible to medication-related harm.

How often are the Beers Criteria updated?

The AGS typically reviews and updates the Beers Criteria every three to four years to incorporate new evidence, medications, and clinical considerations. The most recent update was in 2023.

What categories of medications do the Beers Criteria cover?

The criteria categorize medications as: those to avoid in most older adults, those to avoid in older adults with specific diseases or syndromes, those to be used with caution, clinically important drug-drug interactions, and medications that require dose adjustment based on kidney function.

Are the Beers Criteria absolute contraindications?

No, the Beers Criteria are not absolute contraindications. They are intended as a guide to stimulate clinical decision-making, emphasizing that individualized patient care, clinical judgment, and consideration of patient goals are always paramount. There may be rare instances where a PIM is the best option.

What is a 'Potentially Inappropriate Medication' (PIM)?

A PIM is any medication whose risks typically outweigh its benefits in older adults, especially when there are safer or more effective alternatives available, or when its use is associated with a high risk of adverse drug events in this population.

How do the Beers Criteria relate to the CGP exam?

The Beers Criteria are a foundational topic for the CGP exam, frequently appearing in case studies and direct questions. Competence in applying these criteria is crucial for demonstrating expertise in geriatric medication management and patient safety.

Beers Criteria for PIMs: Essential for CGP Certified Geriatric Pharmacist Exam Success

Understanding the Beers Criteria: A Cornerstone for the CGP Certified Geriatric Pharmacist Exam

As an expert pharmacy education writer for PharmacyCert.com, I can attest that few topics are as foundational to geriatric pharmacotherapy as the American Geriatrics Society (AGS) Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. For any pharmacist aspiring to pass the CGP Certified Geriatric Pharmacist exam, a comprehensive understanding of these criteria is not just recommended—it's absolutely essential. As of April 2026, the 2023 update of the Beers Criteria remains the authoritative guide, and its principles will heavily influence your success on the exam.

Geriatric patients present unique challenges in medication management due to age-related physiological changes, multiple comorbidities, polypharmacy, and an increased susceptibility to adverse drug reactions (ADRs). The Beers Criteria provide a critical framework for identifying medications that pose a higher risk to older adults, thereby enhancing patient safety and optimizing therapeutic outcomes. Mastering this topic demonstrates your ability to navigate complex medication regimens and advocate for safer, more effective care for the elderly.

Key Concepts of the Beers Criteria

The Beers Criteria define Potentially Inappropriate Medications (PIMs) as drugs whose risks generally outweigh their benefits in older adults, especially when safer or equally effective alternatives are available, or when their use is associated with a high risk of adverse drug events (ADEs) in this population. It’s crucial to understand that these criteria are a guide, not a rigid set of rules. Clinical judgment, patient-specific factors, and individual goals of care always take precedence.

Categories of the Beers Criteria (2023 Update)

The AGS Beers Criteria organize PIMs into several key categories, each with specific implications for geriatric care:

Medications to Avoid in Most Older Adults: These are drugs that are generally considered inappropriate due to high risk of adverse effects, limited efficacy, or the availability of safer alternatives.
- Examples: First-generation antihistamines (e.g., diphenhydramine), certain tricyclic antidepressants (e.g., amitriptyline), long-acting benzodiazepines (e.g., diazepam), muscle relaxants (e.g., carisoprodol), and non-selective NSAIDs chronically without gastroprotective agents (especially for those with high GI risk).
Medications to Avoid in Older Adults with Specific Diseases or Syndromes: Certain medications can exacerbate existing conditions common in the elderly.
- Examples: Non-steroidal anti-inflammatory drugs (NSAIDs) in patients with heart failure (due to fluid retention and exacerbation of HF), anticholinergics in dementia (can worsen cognitive impairment), sulfonylureas like glyburide in renal impairment (increased risk of hypoglycemia), certain antidepressants in patients with a history of falls.
Medications to Be Used with Caution: These drugs may be acceptable in some older adults but require careful monitoring, dose adjustments, or specific patient education due to potential risks.
- Examples: Digoxin (narrow therapeutic index, increased toxicity risk with renal impairment), direct oral anticoagulants (DOACs) (bleeding risk, especially in frail older adults), selective serotonin reuptake inhibitors (SSRIs) (risk of hyponatremia, falls), proton pump inhibitors (PPIs) for long-term use (risk of C. difficile infection, bone fractures).
Clinically Important Drug-Drug Interactions: Identifies combinations of drugs that should be avoided due to significant interaction risks.
- Examples: Warfarin with NSAIDs (increased bleeding risk), opioids with benzodiazepines (increased risk of respiratory depression and sedation).
Medications That Should Be Dose-Adjusted Based on Kidney Function: Highlights drugs that require dosage modification in older adults with impaired renal function, which is common with aging.
- Examples: Many antibiotics, some direct oral anticoagulants, gabapentin, metformin.

Understanding the "why" behind each recommendation is key. For instance, age-related physiological changes like decreased renal and hepatic function, reduced body water, increased body fat, and altered receptor sensitivity all contribute to an older adult's heightened vulnerability to medication side effects. Polypharmacy, the use of multiple medications, further compounds this risk by increasing the likelihood of drug-drug and drug-disease interactions.

How the Beers Criteria Appears on the CGP Exam

The CGP Certified Geriatric Pharmacist practice questions will frequently test your knowledge and application of the Beers Criteria. Expect the following question styles:

Case Studies: This is the most common format. You'll be presented with a detailed patient profile, including age, comorbidities, current medications, and potentially recent lab values or symptoms. Your task will be to identify PIMs, explain *why* they are inappropriate based on the Beers Criteria, and propose safer, evidence-based alternatives or management strategies.
Direct Recall Questions: These might ask you to identify a specific medication as a PIM for a general older adult population or for a patient with a particular condition (e.g., "Which of the following is considered a PIM for an 85-year-old patient with a history of chronic heart failure?").
Pharmacokinetic/Pharmacodynamic Implications: Questions might link age-related physiological changes to the increased risk associated with certain PIMs. For example, why a drug with a long half-life is problematic in the elderly.
Clinical Scenarios and Prioritization: You might be asked to prioritize medication changes in a complex patient case, focusing on deprescribing PIMs or mitigating their risks. Questions may also involve communicating these risks effectively to prescribers, patients, or caregivers.

The exam won't just ask you to list PIMs; it will challenge you to apply the criteria critically, justify your reasoning, and demonstrate a patient-centered approach to geriatric medication management.

Study Tips for Mastering the Beers Criteria

To excel on the CGP exam, an efficient and thorough approach to studying the Beers Criteria is essential:

Understand the Rationale: Don't just memorize lists. Focus on *why* each medication is deemed inappropriate. Understand the mechanism of harm (e.g., anticholinergic burden, CNS depression, prolonged half-life, increased fall risk, exacerbation of disease states).
Categorize and Group: Create your own tables or flashcards grouping PIMs by drug class, adverse effect profile, and specific disease states. This helps in recall and application.
Review the Official AGS Beers Criteria Document: Familiarize yourself with the structure, appendices, and nuances of the most recent 2023 publication. Pay attention to the strength of recommendations and quality of evidence.
Practice with Case Studies: Actively work through numerous geriatric patient cases. Identify PIMs, suggest alternatives, and articulate your clinical reasoning. This is where CGP Certified Geriatric Pharmacist practice questions and free practice questions become invaluable.
Link to Other CGP Topics: The Beers Criteria are interconnected with polypharmacy, deprescribing, fall prevention, cognitive impairment, and management of specific geriatric syndromes. Integrate your understanding across these topics.
Focus on Alternatives: The exam often requires you to not just identify a PIM but to suggest a safer, appropriate alternative. Have a mental list of common PIMs and their preferred substitutes.
Create Mnemonics: For particularly challenging lists or categories, develop memory aids to help with recall under pressure.

Common Mistakes to Watch Out For

Even experienced pharmacists can make mistakes when applying the Beers Criteria. Be mindful of these common pitfalls:

Treating Beers as Absolute Contraindications: The most significant mistake is forgetting that the Beers Criteria are guidelines. There may be rare, justified instances where a PIM is the only or best option for a patient, particularly in hospice care or when patient goals prioritize symptom control over medication risk reduction. Always consider the individual patient, their preferences, and their life expectancy.
Not Considering Alternatives: Simply identifying a PIM isn't enough. The exam expects you to propose a safer, equally effective, and appropriate alternative. Failing to do so will result in lost points.
Ignoring Patient-Specific Factors: Overlooking a patient's comorbidities, allergies, current symptoms, or personal goals of care when applying the criteria. Medication management must always be individualized.
Overlooking Drug-Disease/Syndrome Interactions: Focusing solely on general PIMs or drug-drug interactions and missing those specifically linked to a patient's disease state (e.g., anticholinergics in a patient with dementia).
Using Outdated Information: The Beers Criteria are updated periodically. Ensure you are studying the most current version (2023 for April 2026 exam).
Lack of Justification: On the exam, it's not enough to state that a drug is a PIM; you must clearly articulate *why* it's inappropriate and what the potential risks are for that specific patient.

Quick Review / Summary

The AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults are an indispensable tool for geriatric pharmacists and a critical component of the CGP Certified Geriatric Pharmacist exam. They guide healthcare professionals in identifying medications whose risks outweigh their benefits in older adults, thereby reducing adverse drug events and improving patient safety.

Remember, the criteria are a dynamic guide designed to promote thoughtful clinical decision-making, not a rigid rulebook. Success on the CGP exam, and in your practice, hinges on your ability to apply these criteria judiciously, considering each patient's unique circumstances, and always advocating for the safest and most effective medication regimens. Continue to engage with practice questions and case studies to solidify your understanding, and refer to the Complete CGP Certified Geriatric Pharmacist Guide for further resources as you prepare for this challenging and rewarding certification.